





Seamless Corporation: Seamless Sales Signs New Expansive Memorandum of Understanding With World Renowned Dr. Gadget
LAS VEGAS, NV--(Marketwire - June 25, 2009) - Seamless Corporation (
This will mark the beginning of the new expansive marketing program for the Seamless Sales eCommerce website. This is only the beginning. Many more aspects of this program will be added in the coming days and weeks with the assistance of Dr. Gadget. Advertising and marketing of the website will be expanded to radio, print media Television, internet and direct response marketing. This will lead to a massive pre-holiday campaign that will be the platform to the eCommerce site of the future.
"Seamless Sales will be bringing new products to its website with the assistance of Dr. Gadget and with increase traffic to the site with our new web marketing program all of which should translate to increased sales," stated Al Reda, CEO of Seamless Corp.
About Dr. Gadget
DR. GADGET, AKA DAVE DETTMAN, is an expert and liaison to hundreds of electronic corporations in all genres of electronics for men and women. Dr. Gadget is currently a regular contributor to ABC'S "THE VIEW," "THE MONTEL WILLIAMS SHOW," and has been seen on such shows as "THE TONY DANZA SHOW," "THE WAYNE BRADY SHOW," "LET'S MAKE A DEAL," "EXTRA," "THE OTHER HALF," and HGTV. More information on Dr. Gadget is available at [ www.doctorgadget.com ]
About Seamless Corporation
Seamless Corporation ([ www.seamlesscorp.com ]) is quoted on the (
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.